Quantcast
  

Monday, September 15, 2014         

TO ACCESS SUBSCRIBER CONTENT:
Current Print Subscribers
ACTIVATE account
- OR -
LOGIN or SUBSCRIBE
for full digital access

Hanabusa, Schatz differ on Medicare drug rebates

The senator and his challenger, who generally share the same views, disagree on this matter of policy

By Derrick DePledge

POSTED: 01:30 a.m. HST, Aug 05, 2013

~~<p>Drug companies were spared from mandatory rebates when Medicare Part D, the prescription drug benefit for seniors and the disabled, took effect in 2006.</p>
<p>Rather than being forced by federal law to offer rebates, drug companies can negotiate discounts with private insurers and pharmacy benefit managers, a competitive environment that many contend has helped keep premiums low and contained spending growth.</p>
~~

Drug companies were spared from mandatory rebates when Medicare Part D, the prescription drug benefit for seniors and the disabled, took effect in 2006.

Rather than being forced by federal law to offer rebates, drug companies can negotiate discounts with private insurers and pharmacy benefit managers, a competitive environment that many contend has helped keep premiums low and contained spending growth. Login for more...



Login or sign up below for the complete story

Print Subscribers
ACTIVATION
Current print subscribers, activate your premium content account for unlimited online access & commenting
New Subscribers
Find subscription offers in your area and choose the package that suits your reading preferences.

14-DAY PASS
14 day premium online access and commenting ability on StarAdvertiser.com